Australia markets close in 4 hours 44 minutes

Pharming Group N.V. (0QCO.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.8083+0.0293 (+3.76%)
At close: 06:19PM BST
Full screen
Previous close0.7790
BidN/A x N/A
AskN/A x N/A
Day's range0.8000 - 0.8095
52-week range0.8000 - 0.8095
Avg. volumeN/A
Market cap5.038M
Beta (5Y monthly)0.86
PE ratio (TTM)0.54
EPS (TTM)0.0150
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders

    Leiden, The Netherlands, September 25, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted all proposals on the EGM agenda. Shareholders approved the appointment of Dr. Richard Peters as Non-Executive director for a period of four years. As a result, Dr. Peters succeeds Mr. Paul Sekhri as Chair of the Board of Directors with immediate effect. Deborah Jorn, Vice-Chair of the

  • PR Newswire

    Pharming Group to participate in September investor conferences

    Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management will participate in the following investor conferences in the U.S. in the month of September:

  • PR Newswire

    Pharming Group to convene Extraordinary General Meeting of Shareholders

    Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM/Nasdaq: PHAR) announces it will hold an Extraordinary General Meeting of Shareholders (EGM) on Monday, September 25, 2023 at 14:00 CEST. The Notice to Convene, Explanatory Notes, Voting information, meeting documents and Form of Proxy can be found on the Company's website under Investors/Shareholder Meetings.